Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study.

Cancer Manag Res · 2024 · PMC10840531 · PMID 38318097

Europe PMC DOI

hedged sentences

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

marginally significantP =0.057so close (0.05 < p ≤ 0.1)

47 Interestingly, we also found that patients with a number of metastases sites ≤3 conferred a trend for superior OS compared with that of a number of metastases sites >3 (median OS: 13.1 vs 7.5 months), even the difference was marginally significant ( P =0.057).

also in 26,082 other papers

showed a trendno p-value reported

Interestingly, it seemed that patients with liver metastasis showed a trend for worse PFS compared to those without liver metastasis (median PFS: 4.5 vs 5.8 months), although the difference was not statistically significant ( P =0.095).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.